Antifungal Susceptibilities of the Species of the Pseudallescheria boydii Complex
- 1 December 2006
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 50 (12), 4211-4213
- https://doi.org/10.1128/aac.00981-06
Abstract
Eighty-four isolates belonging to eight species that constitute the Pseudallescheria boydii complex were tested against 11 antifungal agents by using the microdilution method. There were significant differences among the species, with Scedosporium aurantiacum being the most resistant. In general, voriconazole was the most active drug, followed by posaconazole.Keywords
This publication has 17 references indexed in Scilit:
- Scedosporium apiospermum mycetoma with bone involvement successfully treated with voriconazoleTransactions of the Royal Society of Tropical Medicine and Hygiene, 2006
- Invasive Fungal Pathogens: Current Epidemiological TrendsClinical Infectious Diseases, 2006
- Disseminated Scedosporium apiospermum Infection in a Cystic Fibrosis Patient After Double-lung TransplantationThe Journal of Heart and Lung Transplantation, 2006
- Disseminated Pseudallescheria boydii infection successfully treated with voriconazoleJournal of Neurology, Neurosurgery & Psychiatry, 2005
- In Vitro Synergistic Interaction between Amphotericin B and Micafungin against Scedosporium sppAntimicrobial Agents and Chemotherapy, 2005
- Aspergillus lentulus sp. nov., a New Sibling Species of A. fumigatusEukaryotic Cell, 2005
- Correlation between In Vitro Susceptibility of Scedosporium apiospermum to Voriconazole and In Vivo Outcome of Scedosporiosis in Guinea PigsAntimicrobial Agents and Chemotherapy, 2004
- Infection of the CNS by Scedosporium apiospermum after near drowning. Report of a fatal case and analysis of its confounding factorsJournal of Clinical Pathology, 2004
- Flucytosine Resistance Is Restricted to a Single Genetic Clade of Candida albicansAntimicrobial Agents and Chemotherapy, 2004
- Treatment ofScedosporium apiospermumBrain Abscesses with PosaconazoleClinical Infectious Diseases, 2002